XML 74 R28.htm IDEA: XBRL DOCUMENT v3.20.1
Note 22 - Selected Quarterly Financial Data (Unaudited)
12 Months Ended
Dec. 31, 2019
Notes to Financial Statements  
Quarterly Financial Information [Text Block]
Note
22
- Selected Quarterly Financial Data (Unaudited)
 
The following tables contain unaudited statement of operations information for each quarter of
2019
and
2018.
The operating results for any quarter are
not
necessarily indicative of results for any future period.
 
2019 Quarters Ended:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(in thousands, except per share data)
 
Mar. 31
   
June 30
   
Sept. 30
   
Dec. 31
   
Total Year
 
Revenues:
                                       
Grant revenue
  $
-
    $
-
    $
-
    $
-
    $
-
 
License revenue with affiliate
   
40
     
158
     
-
     
-
     
198
 
Total revenues
   
40
     
158
     
-
     
-
     
198
 
Expenses:
                                       
Research and development
   
3,342
     
3,413
     
3,792
     
2,140
     
12,687
 
Selling, general and administrative
   
3,355
     
3,240
     
3,395
     
2,414
     
12,404
 
Total expenses
   
6,697
     
6,653
     
7,187
     
4,554
     
25,091
 
Operating loss
   
(6,657
)    
(6,495
)    
(7,187
)    
(4,554
)    
(24,893
)
Other income / (expense), net
   
120
     
58
     
61
     
(2,821
)    
(2,582
)
Net (loss) / income
  $
(6,537
)   $
(6,437
)   $
(7,126
)   $
(7,375
)   $
(27,475
)
Net (loss) / income per common share - basic and diluted
  $
(0.20
)   $
(0.20
)   $
(0.22
)   $
(0.21
)   $
(0.84
)
Weighted average number of common shares outstanding - basic and diluted
   
32,142
     
32,189
     
32,189
     
34,597
     
32,784
 
 
2018 Quarters Ended:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(in thousands, except per share data)
 
Mar. 31
   
June 30
   
Sept. 30
   
Dec. 31
   
Total Year
 
Revenues:
                                       
Grant revenue
  $
-
    $
695
    $
70
    $
-
    $
765
 
License revenue with affiliate
   
204
     
356
     
159
     
304
     
1,023
 
Total revenues
   
204
     
1,051
     
229
     
304
     
1,788
 
Expenses:
                                       
Research and development
   
3,118
     
2,879
     
2,197
     
2,368
     
10,562
 
Selling, general and administrative
   
1,926
     
1,208
     
1,500
     
2,787
     
7,421
 
Total expenses
   
5,044
     
4,087
     
3,697
     
5,155
     
17,983
 
Operating loss
   
(4,840
)    
(3,036
)    
(3,468
)    
(4,851
)    
(16,195
)
Other income / (expense), net
   
328
     
(16
)    
(459
)    
(4,191
)    
(4,338
)
Net (loss) / income
  $
(4,512
)   $
(3,052
)   $
(3,927
)   $
(9,042
)   $
(20,533
)
AEROSURF warrant dividend
   
-
     
-
     
-
     
(12,505
)    
(12,505
)
Deemed dividend on preferred stock
   
-
     
-
     
-
     
(1,718
)    
(1,718
)
Net (loss) / income attributable to common shareholders
  $
(4,512
)   $
(3,052
)   $
(3,927
)   $
(23,265
)   $
(34,756
)
Net (loss) / income per common share - basic and diluted
  $
(1.40
)   $
(0.81
)   $
(1.04
)   $
(3.24
)   $
(7.74
)
Weighted average number of common shares outstanding - basic and diluted
   
3,227
     
3,751
     
3,769
     
7,191
     
4,493